Award
Delivery Order #SPE2DR26FFM4S
Delivery Order for Novolog Insulin via AmerisourceBergen under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$5,329.20
Ceiling
$5,329.20
Awarded
February 12, 2026
Period of Performance
Feb 12, 2026 – Feb 13, 2026
Identifier
SPE2DR26FFM4S
NAICS
424210
This award constitutes a delivery order under a pre-existing indefinite delivery vehicle (IDV) contract with AmerisourceBergen Drug Corp, a major healthcare company specializing in pharmaceutical distribution. The specific procurement involves Novolog 100 UNIT/ML FlexPen 3ML, an insulin product essential for diabetes management. This contract supports the agency's ongoing efforts to maintain a reliable supply of critical pharmaceutical products, directly impacting patient care by ensuring medicines are available when and where needed. The scope covers delivery of the specified insulin product to a designated location in Conshohocken, Pennsylvania, occurring within a tightly defined short-term period. The award is a follow-on action linked to the broader pharmaceutical distribution IDV, reflecting a long-term partnership. While the award was made as a delivery order under the existing IDV, this method streamlines procurement for essential medical supplies without necessitating new competitive bidding. Key dates include the narrow window for performance in early 2026, emphasizing timely fulfillment.
Description
4570822161!NOVOLOG 100 UNIT/ML FLEXPEN 3ML